Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amy Eckert

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Journal of AHIMA|November 4, 2010
ICD-9-CM coding guidance for LTC facilitiesNancy Benson, June Bronnert, Amy Eckert, et al.
Molecular Biosystems|April 14, 2011
A genome-wide RNAi screen identifies novel targets of neratinib sensitivity leading to neratinib and paclitaxel combination drug treatmentsAttila A Seyhan, Usha Varadarajan, Sung Choe, et al.
Journal of Medicinal Chemistry|October 2, 2007
Estrogen receptor dependent inhibitors of NF-kappaB transcriptional activation-1 synthesis and biological evaluation of substituted 2-cyanopropanoic acid derivatives: pathway selective inhibitors of NF-kappaB, a potential treatment for rheumatoid arthritisThomas J Caggiano, Antony Brazzale, Douglas M Ho, et al.
Journal of Medicinal Chemistry|December 14, 2004
Synthesis and activity of substituted 4-(indazol-3-yl)phenols as pathway-selective estrogen receptor ligands useful in the treatment of rheumatoid arthritisRobert J Steffan, Edward Matelan, Mark A Ashwell, et al.
Current Topics in Medicinal Chemistry|February 4, 2006
Control of chronic inflammation with pathway selective estrogen receptor ligandsRobert J Steffan, Edward Matelan, Mark A Ashwell, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Journal of AHIMA|November 4, 2010
ICD-9-CM coding guidance for LTC facilitiesNancy Benson, June Bronnert, Amy Eckert, et al.
Molecular Biosystems|April 14, 2011
A genome-wide RNAi screen identifies novel targets of neratinib sensitivity leading to neratinib and paclitaxel combination drug treatmentsAttila A Seyhan, Usha Varadarajan, Sung Choe, et al.
Journal of Medicinal Chemistry|October 2, 2007
Estrogen receptor dependent inhibitors of NF-kappaB transcriptional activation-1 synthesis and biological evaluation of substituted 2-cyanopropanoic acid derivatives: pathway selective inhibitors of NF-kappaB, a potential treatment for rheumatoid arthritisThomas J Caggiano, Antony Brazzale, Douglas M Ho, et al.
Journal of Medicinal Chemistry|December 14, 2004
Synthesis and activity of substituted 4-(indazol-3-yl)phenols as pathway-selective estrogen receptor ligands useful in the treatment of rheumatoid arthritisRobert J Steffan, Edward Matelan, Mark A Ashwell, et al.
Current Topics in Medicinal Chemistry|February 4, 2006
Control of chronic inflammation with pathway selective estrogen receptor ligandsRobert J Steffan, Edward Matelan, Mark A Ashwell, et al.
Pageof 1